Harms of Intermittent vs Continuous Androgen-Deprivation Therapy for Prostate Cancer

JAMA Oncol. 2016 Apr;2(4):461-2. doi: 10.1001/jamaoncol.2015.4682.
No abstract available

Publication types

  • Comment

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*

Substances

  • Androgen Antagonists